James E. Hunter

Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma

Larry E. Puls, Deborah E. Powell, Paul D. DePriest et al. · Gynecologic Oncology · 1992 · 166 citations

Veterinary Medicine, Oncology, Pathology +12

Endometrioid carcinoma of the ovary and endometriosis: The association in postmenopausal women

Paul D. DePriest, Evelyn R. Banks, Deborah E. Powell et al. · Gynecologic Oncology · 1992 · 115 citations

Medicine, Gynecology, Oncology +14

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

Ignace Vergote, N. Finkler, J. Del Campo et al. · European Journal of Cancer · 2009 · 102 citations

Medicine, Oncology, Pharmacology +16

A concise strategy for the syntheses of indole alkaloids of the heteroyohimboid and corynantheioid families. Total syntheses of (.+-.)-tetrahydroalstonine, (.+-.)-cathenamine and (.+-.)-geissoschizine

Stephen F. Martin, B. BENAGE, James E. Hunter · Journal of the American Chemical Society · 1988 · 66 citations

Pharmacy, Chemistry, Medicinal Chemistry +11

The Prognostic and Therapeutic Implications of Cytologic Atypia in Patients with Endometrial Hyperplasia

James E. Hunter, Denise Tritz, Michael Howell et al. · Gynecologic Oncology · 1994 · 62 citations

Medicine, Gynecology, Pathology +15